Drug General Information |
Drug ID |
D0E7PQ
|
Former ID |
DAP001082
|
Drug Name |
Vorinostat
|
Synonyms |
NHNPODA; SAHA; SHH; Zolinza; Merck brand of Vorinostat; OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE; SAHA cpd; Suberanilohydroxamic acid; Suberoylanilide hydroxamic acid; Vorinostat MSD; Vorinostat [USAN]; M344; MK0683; SKI390; WIN64652; MK-0683; SAHA, Suberoylanilide hydroxamic acid; SW-064652; Zolinza (TN); Vorinostat (JAN/USAN); N1-hydroxy-N8-phenyloctanediamide; Zolinza, MK-0683, SAHA; N'-hydroxy-N-phenyloctanediamide; N-Hydroxy-N'-phenyl octanediamide; N-Hyrdroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyloctanediamide; N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide; Vorinostat (HDAC inhibitor)
|
Drug Type |
Small molecular drug
|
Therapeutic Class |
Anticancer Agents
|
Company |
Merck
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C14H20N2O3
|
InChI |
InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)
|
InChIKey |
WAEXFXRVDQXREF-UHFFFAOYSA-N
|
CAS Number |
CAS 149647-78-9
|
PubChem Compound ID |
|
PubChem Substance ID |
830547, 832844, 5620782, 7890463, 8153256, 12015019, 14710657, 14823867, 26684150, 29224365, 46393757, 46508989, 46519184, 47207977, 48426290, 49645508, 50070170, 50070537, 50071316, 50113029, 53788318, 56311712, 56312417, 56312644, 56314569, 57322702, 68530763, 75748492, 85736432, 87226482, 92708291, 92719823, 99350949, 99436957, 103174146, 104170365, 104171411, 104308873, 118048589, 121362164, 124756962, 124766849, 124795966, 124893441, 124893442, 125163768, 125335517, 126591282, 126628079, 126649066
|
SuperDrug ATC ID |
L01XX38
|
Target and Pathway |
References |